These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 153768)

  • 61. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.
    Nader HB; Dietrich CP; Buonassisi V; Colburn P
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3565-9. PubMed ID: 2954157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Infrared spectroscopy of heparins suggests that the region 750-950 cm-1 is sensitive to changes in iduronate residue ring conformation.
    Grant D; Long WF; Moffat CF; Williamson FB
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):193-7. PubMed ID: 2018474
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proteoglycans: structure, function, and role in neoplasia.
    Iozzo RV
    Lab Invest; 1985 Oct; 53(4):373-96. PubMed ID: 2413275
    [No Abstract]   [Full Text] [Related]  

  • 64. Heparin-like polysaccharides in intra- and extravascular coagulation reactions.
    Lindahl U; Pejler G
    Acta Med Scand Suppl; 1987; 715():139-44. PubMed ID: 2954435
    [No Abstract]   [Full Text] [Related]  

  • 65. Heparan structure and the modulation of angiogenesis.
    Long WF; Williamson FB
    Med Hypotheses; 1984 Apr; 13(4):385-94. PubMed ID: 6203020
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment.
    Mohamed S; He QQ; Singh AA; Ferro V
    Adv Carbohydr Chem Biochem; 2020; 77():71-117. PubMed ID: 33004112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase.
    Smeds E; Feta A; Kusche-Gullberg M
    Glycobiology; 2010 Oct; 20(10):1274-82. PubMed ID: 20554947
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural characteristics of heparan sulfates with varying sulfate contents.
    Cifonelli JA; King JA
    Biochemistry; 1977 May; 16(10):2137-41. PubMed ID: 140700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates.
    Barragan A; Spillmann D; Kremsner PG; Wahlgren M; Carlson J
    Exp Parasitol; 1999 Feb; 91(2):133-43. PubMed ID: 9990341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
    Clarke D; Katoh O; Gibbs RV; Griffiths SD; Gordon MY
    Cytokine; 1995 May; 7(4):325-30. PubMed ID: 8589262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isolation and partial characterization of three induced enzymes from Flavobacterium heparinum involved in the degradation of heparin and heparitin sulfates.
    Silva ME; Dietrich CP
    Biochem Biophys Res Commun; 1974 Feb; 56(4):965-72. PubMed ID: 4826471
    [No Abstract]   [Full Text] [Related]  

  • 72. The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymers.
    Luscombe M; Marshall S; Pepper DS; Holbrook JJ
    Biochim Biophys Acta; 1981 Nov; 678(1):137-42. PubMed ID: 6796130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific binding of the chemokine platelet factor 4 to heparan sulfate.
    Stringer SE; Gallagher JT
    J Biol Chem; 1997 Aug; 272(33):20508-14. PubMed ID: 9252363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bioengineered heparins and heparan sulfates.
    Fu L; Suflita M; Linhardt RJ
    Adv Drug Deliv Rev; 2016 Feb; 97():237-49. PubMed ID: 26555370
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Binding of heparin and heparan sulphate to rat liver cells.
    Kjellén L; Oldberg A; Rubin K; Höök M
    Biochem Biophys Res Commun; 1977 Jan; 74(1):126-33. PubMed ID: 138421
    [No Abstract]   [Full Text] [Related]  

  • 76. Recent advances in biotechnology for heparin and heparan sulfate analysis.
    Qiao M; Lin L; Xia K; Li J; Zhang X; Linhardt RJ
    Talanta; 2020 Nov; 219():121270. PubMed ID: 32887160
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cloning and Expression of Heparinase Gene from a Novel Strain Raoultella NX-TZ-3-15.
    Li Y; Lin Y; Jiang Y; Mehwish HM; Rajoka MSR; Zhao L
    Appl Biochem Biotechnol; 2022 Oct; 194(10):4971-4984. PubMed ID: 35679015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Optical characteristics of carboxyl group in relation to the circular dichroic properties and dissociation constants of glycosaminoglycans.
    Park JW; Chakrabarti B
    Biochim Biophys Acta; 1978 Dec; 544(3):667-75. PubMed ID: 31931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The cell surface of a restrictive fenestrated endothelium. II. Dynamics of cationic ferritin binding and the identification of heparin and heparan sulfate domains on the choriocapillaris.
    Pino RM
    Cell Tissue Res; 1986; 243(1):157-64. PubMed ID: 2935259
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin.
    Yang J; Song Y; Jin W; Xia K; Burnett GC; Qiao W; Bates JT; Pomin VH; Wang C; Qiao M; Linhardt RJ; Dordick JS; Zhang F
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.